Humanized immunoglobulin reactive with α4β7...

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023530, C435S325000, C435S328000, C435S320100

Reexamination Certificate

active

11511164

ABSTRACT:
The present invention relates to isolated nucleic acids encoding humanized immunoglobulins having binding specificity for α4β7 integrin, isolated nucleic acids encoding a humanized immunoglobulin heavy chain and isolated nucleic acids encoding a humanized light chain having binding specificity for α4β7 integrin. The invention also relates to expression vectors and host cells comprising a nucleotide sequence which encodes a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for α4β7. The invention further relates to methods of preparing a humanized immunoglobulin, humanized immunoglobulin heavy chain and humanized immunoglobulin light chain that has binding specificity for α4β7 integrin.

REFERENCES:
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5225539 (1993-07-01), Winter
patent: 5258498 (1993-11-01), Huston et al.
patent: 5403919 (1995-04-01), Butcher
patent: 5530101 (1996-06-01), Queen et al.
patent: 5538724 (1996-07-01), Butcher et al.
patent: 5558864 (1996-09-01), Bendig et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5624821 (1997-04-01), Winter et al.
patent: 5648260 (1997-07-01), Winter et al.
patent: 5665595 (1997-09-01), Petell et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5840299 (1998-11-01), Bendig et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 5871734 (1999-02-01), Lobb et al.
patent: 5888507 (1999-03-01), Burkly
patent: 5932214 (1999-08-01), Lobb et al.
patent: 6551593 (2003-04-01), Ringler et al.
patent: 0 239 400 (1987-09-01), None
patent: 0 303 463 (1994-11-01), None
patent: 2209757 (1990-10-01), None
patent: 63 03990 (1994-11-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 88/07089 (1988-09-01), None
patent: WO 89/07142 (1989-08-01), None
patent: WO 90/07321 (1990-07-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/03252 (1991-03-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 92/11018 (1992-07-01), None
patent: WO 93/02191 (1993-02-01), None
patent: WO 93/15764 (1993-08-01), None
patent: WO 94/12214 (1994-06-01), None
patent: WO 94/13312 (1994-06-01), None
patent: WO 94/16094 (1994-07-01), None
patent: WO 94/17828 (1994-08-01), None
patent: WO 94/29351 (1994-12-01), None
patent: WO 95/19790 (1995-07-01), None
patent: WO 97/18838 (1997-05-01), None
patent: WO 98/06248 (1998-02-01), None
patent: WO 88/07089 (1998-09-01), None
Webster's II New Riverside University Dictionary, The Riverside Publishing Company, 1988, p. 755.
Mountain, A. and Adair, J.R., “Engineering Antibodies for Therapy,”Biotechnol. Genet. Eng. Rev., 10:1-142 (1992).
Woodside, D.G., et al., “Specific Inhibition of T Lymphocyte Coactivation by Triggering Integrin β1 Reveals Convergence of β1, β2, and β7 Signaling Pathways,”J. Immunol., 157:700-706 (1996).
van der Voort, R., et al., “Paracrine Regulation of Germinal Center B Cell Adhesion Through the c-Met-Hepatocyte Growth Factor/Scatter Factor Pathway,”J. Exp. Med., 185(12):2121-2131 (1997).
Rott, L.S., et al., “Expression of Mucosal Homing Receptor α4β7 by Circulating CD4+ Cells with Memory for Intestinal Rotavirus,”J. Clin. Invest., 100(5):1204-1208 (1997).
Lobb, R.R., et al., “The Role of α4 Integrins in Lung Pathophysiology,”Eur. Respir. J., 9 (Supp 22):104s-108s (1996).
Goldenberg, D.M., “New Developments in Monoclonal Antibodies for Cancer Detection and Therapy,”CA Cancer J. Clin., 44:43-64 (1994).
Owens, R.J. and Young, R.J., “The Genetic Engineering of Monoclonal Antibodies,”J. Immunol. Methods, 168(2):149-165 (1994).
Lazarovits, A.I. and Karsh, J., “α4β7 Integrin in Rhematoid Arthritis,” InLeucocyte Typing V—White Cell Differentiation Antigens, S.F. Schlossman, et al., eds., (Oxford: Oxford University), pp. 1686-1687 (1995).
Lazarovits, A.I., et al., “Lymphocyte Activation Antigens—I. A Monoclonal Antibody, Anti-Act 1, Defines a New Late Lymphocyte Activation Antigen,”J. Immunol., 133:1857-1862 (1984).
Erle, D.J., et al., “Expression and Function of the MAdCAM-1 Receptor, Integrin α4β7, on Human Leukocytes,”J. Immunol., 153:517-528 (1994).
Postigo, A.A., et al., “α4β7 Integrin Mediates B Cell Binding to Fibronectin and Vascular Cell Adhesion Molecule-1,”J. Immunol., 151:2471-2483 (1993).
Lazarovits, A.I. and Karsh, J., “Differential Expression in Rheumatoid Synovium and Synovial Fluid of α4β7 Integrin—A Novel Receptor for Fibronectin and Vascular Cell Adhesion Molecule-1,”J. Immunol., 151:6482-6489 (1993).
Schweighoffer, T., et al., “Selective Expression of Integrin α4β7 on a Subset of Human CD4+Memory T Cells with Hallmarks of Gut-Trophism,”J. Immunol., 151:717-729 (1993).
Riechmann, L., et al., “Reshaping Human Antibodies for Therapy,”Nature, 332:323-327 (1988).
Bendig, M.M., “Humanization of Rodent Monoclonal Antibodies by CDR Grafting,”Methods: A Companion to Methods of Enzymology, 8:83-93 (1995).
Page, M.J., and Sydenham, M.A., “High Level Expression of the Humanized Monoclonal Antibody Campath-1H in Chinese Hamster Ovary Cells,”Bio/Technol, 9:64-68 (1991).
Bednarczyk, J.L., et al., “Identification of a Combinatorial Epitope Expressed by the Integrin α4β7 Heterodimer Involved in the Regulation of Cell Adhesion,”J. Biol. Chem., 269:8348-8354 (1994).
Yacyshyn, B.R., et al., “Crohn's Disease, Ulcerative Colitis, and Normal Intestinal Lymphocytes Express Integrins in Dissimilar Patterns,”Gastroenterol., 107:1364-1371 (1994).
Pals, S.T., et al., “Expression of the Mucosal Homing Receptor α4β7 in Malignant Lymphomatous Polyposis of the Intestine,”Gastroenterol., 107:1519-1523 (1994).
Teague, T.K., et al., “Integrin α4β7 Co-Stimulation of Human Peripheral Blood T Cell Proliferation,”Cell Adhesion Comm., 2:539-547 (1994).
Tiisala, S., et al., “αEβ7 and α4β7 Integrins Associated with Intraepithelial and Mucosal Homing, are Expressed on Macrophages,”Eur. J. Immunol., 25:411-417 (1995).
Wan, H.C., et al., “Expression of α4β7 Integrin on Eosinophils and Modulation of α4-Integrin-Mediated Eosinophil Adhesion via CD4,”Int. Arch. Allergy Immunol., 107:343-344 (1995).
Berg, E.L., et al., “L-Selectin-Mediated Lymphocyte Rolling on MAdCAM-1,”Nature, 366:695-698 (1993).
Berlin, C., et al., “α4 Integrins Mediate Lymphocyte Attachment and Rolling under Physiologic Flow,”Cell, 80:413-422 (1995).
Yang, Y., et al., “Construction and Adhesive Properties of a Soluble MAdCAM-1-Fc Chimera Expressed in a Baculovirus System: Phylogenetic Conservation of Receptor-Ligand Interaction,”Scand. J. Immunol., 42:235-247 (1995).
Hamann, A., et al., “Role of α4-Integrins in Lymphocyte Homing to Mucosal Tissues In Vivo,”J. Immunol., 152:3282-3293 (1994).
Podolsky, D.K., et al., “Attenuation of Colitis in the Cotton-top Tamarin by Anti-α4 Integrin Monoclonal Antibody,”J. Clin. Invest., 92:372-380 (1993).
Podolsky, D.K., “Inflammatory Bowel Disease (First of Two Parts),”N. Eng. J. Med., 325(13):928-937 (1991).
Podolsky, D.K., “Inflammatory Bowel Disease (Second of Two Parts),”N. Eng. J. Med., 325(14):1008-1016 (1991).
Springer, T.A., “The Sensation and Regulation of Interactions with the Extracellular Environment: The Cell Biology of Lymphocyte Adhesion Receptors,”Annu. Rev. Cell Biol., 6:359-402 (1990).
Picker, L.J. and Butcher, E.C., “Physiological and Molecular Mechanisms of Lymphocyte Homing,”Annu. Rev. Immunol., 10:561-591 (1992).
Hynes, R

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Humanized immunoglobulin reactive with α4β7... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Humanized immunoglobulin reactive with α4β7..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized immunoglobulin reactive with α4β7... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3916851

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.